Google
WGS 株価分析 — GENEDX HOLDINGS CORP. (Healthcare >> Diagnostics & Research)
WGS に関するよくある質問
WGSのPER（株価収益率）は？
GENEDX HOLDINGS CORP.（WGS）は現在PER 189.41倍で取引されています。
WGSのROE（自己資本利益率）は？
GENEDX HOLDINGS CORP.のROEは-30.62%です。
WGSの配当利回りは？
GENEDX HOLDINGS CORP.の配当利回りは0.00%です。
WGSの品質スコア（Quality Score）は？
当社のAIはWGSの総合財務品質を100点中46点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
WGSは今が買い時ですか？
当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
WGSはどのセクターに属しますか？
GENEDX HOLDINGS CORP.はHealthcare >> Diagnostics & Researchセクターに分類されます（NASDAQ市場）
WGS AI Analysis Summary
Our AI summary for WGS: GENEDX HOLDINGS CORP. (NASDAQ), Healthcare >> Diagnostics & Research sector. The stock currently trades at a P/E of 189.41, ROE of -30.62%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 65.11
Price
-3.85
(-5.58%)
Day Change
|
|
|---|
WGS, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
平均ROEが低い
ROEが昨年度比で低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 65.11 |
| PBV / Sector |
8.06 / -29.69
|
| Earning Per Share | -2.47 |
| PE / Sector |
189.41 / 48.18
|
| PEG or PE/Growth / Sector |
-2.59 / 1.64
|
| Average 1M Daily Value |
42.28 M
GREAT
|
| Average 1W Daily Value |
51.37 M
|
| Timing Factors |
|
71% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
60% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:41 |
| Symbol | WGS |
| Name | GENEDX HOLDINGS CORP. |
| Sector | Healthcare >> Diagnostics & Research |
| Market | NASDAQ |
| Listed Shares | 29.69 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 2,047.29 / 38,081.42 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: North Tower, Stamford, CT, United States, 06902
Phone: 888 729 1206
Website: https://www.genedx.com
Employees: 1,300
Description: GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Diagnostics & Research
Click a bubble to view stock details · Bubble size represents market capitalization share
